Clinical Trial Update: Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial assessing persistence of cellular and humoral immune responses after vaccination with GlaxoSmithKline's Hepatitis B vaccine candidates containing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GSK Hepatitis B vaccine candidate containing HBsAg with adjuvants

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 1 | Status: COMPLETED